About
- About Avecho
- Board & Leadership
TPM^® Technology
Portfolio
Invest
- Investor Centre
- Media Centre
Contact

Hit enter to search or ESC to close

Retirement of Non-Executive Director

May 19, 2016

Click here to read more

Post navigation

Phosphagenics Expands License Agreement for Diclofenac Gel

2016 May 19 AGM Chairman and CEO Addresses

Related Posts

Phosphagenics Extends Due Diligence Period for Opioid Patches in Japan

November 10, 2016

Phosphagenics Arbitration Award Issued

November 12, 2018

Quarterly Activities Report and 4C – to 30 June 2022

July 29, 2022July 29, 2022

Recent Posts

Research report | RaaS Watchlist: Waking the Sleeping Giant
August 26, 2025
Media | Avecho featured on 9 News
June 23, 2025
New Sites Commence Recruitment For Phase III Clinical Trial
May 20, 2025

Categories

Analyst Coverage
Company Announcement
Company Report
Investor Webinar
Media Coverage
Newsletter
Press Release
Uncategorised

About us

We see a future where more patients can get even more from their treatments through innovative delivery technologies.

Stay Posted

Stay informed about our latest news and developments.

Leave this field empty if you're human:

About Avecho

TPM^® Technology

Portfolio

Investor Centre
- Investor Centre
- Media Centre

© Copyright 2019 Avecho Biotechnology Ltd.